NCT06599307View on ClinicalTrials.gov

The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis

PHASE2RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Secondary Progressive Multiple Sclerosis (SPMS)
Interventions
DRUG

Rituximab

Rituximab 1gm vial diluted on 500 ml normal saline 0.9%

OTHER

Saline (NaCl 0,9 %) (placebo)

500 ml of normal saline 0.9%

Trial Locations (1)

Unknown

RECRUITING

Kasr Alainy Multiple Sclerosis Unit (KAMSU), Cairo University hospitals., Giza

All Listed Sponsors
lead

Cairo University

OTHER